Evidence map›Paper›PMID 42445498›Full record

ArticleFrontiers in microbiology2026

Marine biofilms as reservoirs of antimicrobial bacteria: molecular identification and functional characterization of epibiotic culturable communities from biofouling invertebrates in northern Tunisia.

Yosra Alouadi, Bilel Hassen, Imen Jaouani, Radhia Mraouna, Jamila Ben Souissi, Monia El Bour

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yosra AlouadiGroup of Aquatic Bacteriology and Biotechnology (GAB2), LR16INSTM05, The National Institute of Science and Technology of the Sea, University of Carthage, Salammbô, Tunisia.
Bilel HassenGroup of Aquatic Bacteriology and Biotechnology (GAB2), LR16INSTM05, The National Institute of Science and Technology of the Sea, University of Carthage, Salammbô, Tunisia.
Imen JaouaniGroup of Aquatic Bacteriology and Biotechnology (GAB2), LR16INSTM05, The National Institute of Science and Technology of the Sea, University of Carthage, Salammbô, Tunisia.
Radhia MraounaGroup of Aquatic Bacteriology and Biotechnology (GAB2), LR16INSTM05, The National Institute of Science and Technology of the Sea, University of Carthage, Salammbô, Tunisia.
Jamila Ben SouissiNational Institute of Agronomy of Tunisia (INAT), Biodiversity, Biotechnology and Climate Change Laboratory (LR11ES09), University Tunis El Manar, Tunis, Tunisia.
Monia El BourGroup of Aquatic Bacteriology and Biotechnology (GAB2), LR16INSTM05, The National Institute of Science and Technology of the Sea, University of Carthage, Salammbô, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marine biofouling communities constitute a rich reservoir of microbial diversity and represent a promising source of bioactive metabolites. In this study, we investigated culturable epibiotic bacteria associated with fouling invertebrates from the Marina in northern Tunisia, with a focus on their enzymatic activities, antimicrobial potential, and antibiotic resistance profiles. A total of 52 bacterial isolates were recovered from 23 fouling invertebrate hosts and characterized using DNA barcoding and molecular identification. The epibiotic culturable bacterial community was dominated by members of the genera

Indexed as

antibiotic resistanceantimicrobial activitybiofoulingDNA barcodingepibiotic culturable bacteriaexoenzymesMarina in northern Tunisia

Identifiers

PMID42445498
PMCPMC13357989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.